Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 4 studies | 20% ± 4% | |
GABAergic neuron | 3 studies | 30% ± 5% | |
glutamatergic neuron | 3 studies | 33% ± 4% |
Insufficient scRNA-seq data for expression of RNF128 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3306.16 | 226 / 226 | 98% | 78.32 | 399 / 406 |
pancreas | 100% | 992.34 | 328 / 328 | 92% | 77.66 | 163 / 178 |
thymus | 100% | 2003.79 | 652 / 653 | 89% | 90.28 | 537 / 605 |
kidney | 100% | 1051.65 | 89 / 89 | 87% | 60.68 | 782 / 901 |
adrenal gland | 100% | 3673.97 | 258 / 258 | 81% | 38.11 | 187 / 230 |
stomach | 75% | 1604.65 | 271 / 359 | 93% | 67.38 | 266 / 286 |
lung | 90% | 646.41 | 519 / 578 | 56% | 24.33 | 651 / 1155 |
intestine | 45% | 743.86 | 436 / 966 | 96% | 76.18 | 504 / 527 |
bladder | 52% | 1003.81 | 11 / 21 | 80% | 78.94 | 404 / 504 |
esophagus | 38% | 209.29 | 547 / 1445 | 69% | 44.16 | 126 / 183 |
skin | 79% | 490.39 | 1430 / 1809 | 22% | 10.34 | 104 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 74.40 | 1 / 1 |
muscle | 85% | 338.79 | 684 / 803 | 0% | 0 | 0 / 0 |
brain | 65% | 305.78 | 1722 / 2642 | 5% | 0.95 | 34 / 705 |
breast | 47% | 188.01 | 214 / 459 | 18% | 5.73 | 198 / 1118 |
prostate | 46% | 143.00 | 112 / 245 | 8% | 1.72 | 40 / 502 |
uterus | 1% | 2.46 | 2 / 170 | 29% | 16.77 | 133 / 459 |
ovary | 27% | 56.12 | 48 / 180 | 1% | 0.18 | 3 / 430 |
tonsil | 0% | 0 | 0 / 0 | 22% | 6.73 | 10 / 45 |
adipose | 4% | 13.20 | 47 / 1204 | 0% | 0 | 0 / 0 |
heart | 4% | 6.84 | 32 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.29 | 1 / 80 |
spleen | 0% | 3.72 | 1 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 1.30 | 5 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_1904352 | Biological process | positive regulation of protein catabolic process in the vacuole |
GO_0061462 | Biological process | protein localization to lysosome |
GO_0031647 | Biological process | regulation of protein stability |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005770 | Cellular component | late endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF128 |
Protein name | Ring finger protein 128 E3 ubiquitin-protein ligase RNF128 (EC 2.3.2.27) (Gene related to anergy in lymphocytes protein) (GRAIL) (RING finger protein 128) (RING-type E3 ubiquitin transferase RNF128) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that catalyzes 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains formation. Functions as an inhibitor of cytokine gene transcription. Inhibits IL2 and IL4 transcription, thereby playing an important role in the induction of the anergic phenotype, a long-term stable state of T-lymphocyte unresponsiveness to antigenic stimulation associated with the blockade of interleukin production. Ubiquitinates ARPC5 with 'Lys-48' linkages and COR1A with 'Lys-63' linkages leading to their degradation, down-regulation of these cytosleletal components results in impaired lamellipodium formation and reduced accumulation of F-actin at the immunological synapse. Functions in the patterning of the dorsal ectoderm; sensitizes ectoderm to respond to neural-inducing signals. . |
Accessions | Q8TEB7 ENST00000324342.7 [Q8TEB7-2] Q5JSK4 ENST00000255499.3 [Q8TEB7-1] ENST00000418562.5 |